Nancies. Cancer 112, 274sirtuininhibitor83, doi:ten.1002/cncr.23159 (2008). 15. Ito, T. et al. Epidemiological study
Nancies. Cancer 112, 274sirtuininhibitor83, doi:10.1002/cncr.23159 (2008). 15. Ito, T. et al. Epidemiological study of gastroenteropancreatic neuroMASP1 Protein site endocrine GDF-15 Protein manufacturer tumors in Japan. J Gastroenterol 45, 234sirtuininhibitor43, doi:10.1007/s00535-009-0194-8 (2010). 16. Oberg, K. Eriksson, B. Endocrine tumours of the pancreas. Most effective Pract Res Clin Gastroenterol 19, 753sirtuininhibitor81, doi:10.1016/j. bpg.2005.06.002 (2005). 17. Jonkers, Y. M., Ramaekers, F. C. Speel, E. J. Molecular alterations during insulinoma tumorigenesis. Biochim Biophys Acta 1775, 313sirtuininhibitor32, doi:ten.1016/j.bbcan.2007.05.004 (2007). 18. Bertolino, P. et al. Pancreatic beta-cell-specific ablation of the several endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma improvement in mice. Cancer Res 63, 4836sirtuininhibitor841 (2003). 19. Jiang, W. J. et al. Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance. Zhonghua Yi Xue Za Zhi 84, 1705sirtuininhibitor709 (2004). 20. Cupisti, K. et al. Lack of MEN1 gene mutations in 27 sporadic insulinomas. Eur J Clin Invest 30, 325sirtuininhibitor29, doi:ten.1046/j.13652362.2000.00620.x (2000). 21. Cao, Y. et al. Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1. Nat Commun 4, 2810, doi:ten.1038/ ncomms3810 (2013). 22. Roldo, C. et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are linked with distinctive pathologic characteristics and clinical behavior. Journal of clinical oncology: official journal of your American Society of Clinical Oncology 24, 4677sirtuininhibitor684, doi:ten.1200/JCO.2005.05.5194 (2006). 23. Missiaglia, E. et al. Pancreatic endocrine tumors: expression profiling evidences a part for AKT-mTOR pathway. Journal of clinical oncology: official journal from the American Society of Clinical Oncology 28, 245sirtuininhibitor55, doi:10.1200/JCO.2008.21.5988 (2010). 24. Speisky, D. et al. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau sufferers. Clin Cancer Res 18, 2838sirtuininhibitor849, doi:ten.1158/1078-0432.CCR-11-2759 (2012). 25. Jiang, X. et al. miR-144/451 Promote Cell Proliferation via Targeting PTEN/AKT Pathway in Insulinomas. Endocrinology 156, 2429sirtuininhibitor439, doi:ten.1210/en.2014-1966 (2015).
Open AccessProtocolA cluster-randomised controlled trial integrating a community-based water, sanitation and hygiene programme, with mass distribution of albendazole to reduce intestinal parasites in Timor-Leste: the WASH for WORMS study protocolSusana Vaz Nery,1 James S McCarthy,two Rebecca Traub,three Ross M Andrews,four Jim Black,five Darren Gray,1 Edmund Weking,6 Jo-An Atkinson,7 Suzy Campbell,1 Naomi Francis,five Andrew Vallely,eight Gail Williams,9 Archie ClementsTo cite: Nery SV, McCarthy JS, Traub R, et al. A cluster-randomised controlled trial integrating a community-based water, sanitation and hygiene programme, with mass distribution of albendazole to lower intestinal parasites in Timor-Leste: the WASH for WORMS investigation protocol. BMJ Open 2015;five:e009293. doi:10.1136/bmjopen-2015009293 Prepublication history for this paper is readily available online. To view these files please pay a visit to the journal on the net (dx.doi.org/10.1136/ bmjopen-2015-009293). Received two July 2015 Revised 25 November 2015 Accepted 27 NovemberABSTRACT Introduction: There’s limited evidence demonstratingthe advantages of community-based water, sanitation and hygiene (WASH) programmes on infe.
